Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, et al. Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies. Pediatrics 2015;136(1):e203-214
Iacobas I, Phung TL, Adams DM, Trenor CC 3rd, Blei F, Fishman DS, et al. Guidance document for hepatic hemangioma (infantile and congenital) evaluation and monitoring. J Pediatr 2018;203(294–300): e292
Christison-Lagay ER, Burrows PE, Alomari A, Dubois J, Kozakewich HP, Lane TS, et al. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg 2007;42(1):62–67 (discussion 67–68)
Kulungowski AM, Alomari AI, Chawla A, Christison-Lagay ER, Fishman SJ. Lessons from a liver hemangioma registry: subtype classification. J Pediatr Surg 2012;47(1):165–170
Dickie B, Dasgupta R, Nair R, Alonso MH, Ryckman FC, Tiao GM, et al. Spectrum of hepatic hemangiomas: management and outcome. J Pediatr Surg 2009;44(1):125–133
Enjolras O, Mulliken JB, Boon LM, Wassef M, Kozakewich HP, Burrows PE. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg 2001;107(7):1647–1654
Article CAS PubMed Google Scholar
Boon LM, Enjolras O, Mulliken JB. Congenital hemangioma: evidence of accelerated involution. J Pediatr 1996;128(3):329–335
Article CAS PubMed Google Scholar
North PE, Waner M, James CA, Mizeracki A, Frieden IJ, Mihm MC Jr. Congenital nonprogressive hemangioma: a distinct clinicopathologic entity unlike infantile hemangioma. Arch Dermatol 2001;137(12):1607–1620
Article CAS PubMed Google Scholar
Nasseri E, Piram M, McCuaig CC, Kokta V, Dubois J, Powell J. Partially involuting congenital hemangiomas: a report of 8 cases and review of the literature. J Am Acad Dermatol 2014;70(1):75–79
Delgado-Miguel C, Triana P, Miguel-Ferrero M, Diaz M, Hierro L, Jara P, et al. Mortality predictive factors in congenital hepatic hemangioma: a case-control study. Eur J Pediatr 2023;182(4):1657–1663
Article CAS PubMed Google Scholar
Rutten C, Ladarre D, Ackermann O, Gonzales E, Guettier C, Franchi-Abella S. Spontaneous evolution patterns of focal congenital hepatic hemangiomas: a case series of 25 patients. Pediatr Radiol 2022;52(6):1048–1060
Gong X, Li Y, Yang K, Chen S, Ji Y. Infantile hepatic hemangiomas: looking backwards and forwards. Precis Clin Med 2022;5(1):pbac006
Article PubMed PubMed Central Google Scholar
Macdonald A, Durkin N, Deganello A, Sellars ME, Makin E, Davenport M. Historical and contemporary management of infantile hepatic hemangioma: a 30-year single-center experience. Ann Surg 2022;275(1):e250–e255
Roebuck D, Sebire N, Lehmann E, Barnacle A. Rapidly involuting congenital haemangioma (RICH) of the liver. Pediatr Radiol 2012;42(3):308–314
Zavras N, Dimopoulou A, Machairas N, Paspala A, Vaos G. Infantile hepatic hemangioma: current state of the art, controversies, and perspectives. Eur J Pediatr 2020;179(1):1–8
Yang K, Peng S, Chen L, Chen S, Ji Y. Efficacy of propranolol treatment in infantile hepatic haemangioma. J Paediatr Child Health 2019;55(10):1194–1200
Ji Y, Chen S, Xiang B, Xu Z, Jiang X, Liu X, et al. Clinical features and management of multifocal hepatic hemangiomas in children: a retrospective study. Sci Rep 2016;6:31744
Article CAS PubMed PubMed Central Google Scholar
Ji Y, Chen S, Yang K, Zhang X, Zhou J, Li L, et al. Efficacy and safety of propranolol vs atenolol in infants with problematic infantile hemangiomas: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg 2021;147(7):599–607
Ji Y, Chen S, Zhou J, Yang K, Zhang X, Xiang B, et al. Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial. Blood 2022;139(11):1619–1630
Article CAS PubMed Google Scholar
Ji Y, Chen S, Yang K, Zhou J, Zhang X, Jiang X, et al. A prospective multicenter study of sirolimus for complicated vascular anomalies. J Vasc Surg 2021;74(5):1673-1681e1673
Lozar Krivec J, Lah N, Glusic M, Velikonja O, Paro-Panjan D. Treatment of symptomatic focal hepatic hemangioma with propranolol in neonates: is it efficient? Pediatr Gastroenterol Hepatol Nutr 2023;26(1):70–77
Article PubMed PubMed Central Google Scholar
Konanur A, Jimenez JE, Kochin M, McCormick A, Salgado C, Yilmaz S, et al. Non-involuting congenital hemangioma with delayed hypertrophy: a case series. Int J Pediatr Otorhinolaryngol 2022;157: 111102
Triana P, Rodriguez-Laguna L, Giacaman A, Salinas-Sanz JA, Martin-Santiago A, Lopez-Santamaria M, et al. Congenital hepatic hemangiomas: clinical, histologic, and genetic correlation. J Pediatr Surg 2020;55(10):2170–2176
Ayturk UM, Couto JA, Hann S, Mulliken JB, Williams KL, Huang AY, et al. Somatic activating mutations in GNAQ and GNA11 are associated with congenital hemangioma. Am J Hum Genet 2016;98(6):1271
Article CAS PubMed PubMed Central Google Scholar
Gestrich CK, Vivero MP, Konczyk DJ, Goss JA, Labow BI, Pearson GD, et al. Papillary hemangioma harbors somatic GNA11 and GNAQ mutations. Am J Surg Pathol 2023;48:106–111
Greene AK, Goss JA. Vascular anomalies: from a clinicohistologic to a genetic framework. Plast Reconstr Surg 2018;141(5):709e–717e
Article CAS PubMed PubMed Central Google Scholar
Rialon KL, Murillo R, Fevurly RD, Kulungowski AM, Christison-Lagay ER, Zurakowski D, et al. Risk factors for mortality in patients with multifocal and diffuse hepatic hemangiomas. J Pediatr Surg 2015;50(5):837–841
Rutten C, Ackermann O, Lambert V, Durand P, Gonzales E, Kreindel TG, et al. Pediatric hepatic hemangiomas: spectrum and prognostic significance of initial ultrasound findings. Pediatr Radiol 2023;53(12):2446–2457
Wei H, Li Y, Li L, Hu Q, Shi M, Cheng L, et al. Novel organoid construction strategy for non-involuting congenital hemangioma for drug validation. J Biol Eng 2023;17(1):32
Comments (0)